Inhibition of tumor growth and alteration of associated macrophage cell type by an HO-1 inhibitor in breast carcinoma-bearing mice

Oncology Research

Volumn 20, Issue 10, 2013, Pages 473-482

  Deng, Rui ^a   Wang, Shi Min ^a   Yin, Tao ^a   Ye, Ting Hong ^a   Shen, Guo Bo ^a   Li, Ling ^a   Zhao, Jing Yi ^a,b   Sang, Ya Xiong ^a   Duan, Xiao Gang ^a   Wei, Yu Quan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

4T1; Heme oxygenase (HO 1); Tumor associated macrophages (TAMs); ZnPPIX

Indexed keywords

ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; ZINC PROPOPORPHYRIN IX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84883005421     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13715991125684     Document Type: Article

References (50)

1. Szarek, W. A.; Su, J.; Song, W.; Xu, Y.; Xu, B.; Liu, G.; Vlahakis, J. Z. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 69:8017-8024; 2009.
2. Kuroda, H.; Murakami, S.; Miyazawa, N.; Kaneko, T.; Ishigatsubo, Y. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells. Lung Cancer 67:31-36; 2010.
3. Lee, S. S.; Yang, S. F.; Tsai, C. H.; Chou, M. C.; Chou, M. Y.; Chang, Y. C. Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. J. Forums Med. Assoc. 107:355-363; 2008.
4. Nuhn, P.; Künzli, B. M.; Hennig, R.; Mitkus, T.; Ramanauskas, T.; Nobiling, R.; Meuer, S. C.; Friess, H.; Berberat, P. O. Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol. Cancer 8:37; 2009.
5. Sass, G.; Leukel, P.; Schmitz, V.; Raskopf, E.; Ocker, M.; Neureiter, D.; Meissnitzer, M.; Tasika, E.; Tannapfel, A.; Tiegs, G. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int. J. Cancer 123:1269-1277; 2008.
6. Deininger, M. H.; Meyermann, R.; Trautmann, K.; Duffner, F.; Grote, E. H.; Wickboldt, J.; Schluesener, H. J. Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Res. 882:1-8; 2000.
7. Torisu-Itakura, H.; Furue, M.; Kuwano, M.; Ono, M. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Cancer Sci. 91:906-910; 2000.
8. Was, H.; Dulak, J.; Jozkowicz, A. Heme oxygenase-1 in tumor biology and therapy. Curr. Drug Targets 11:1551-1570; 2010.
9. Boschetto, P.; Zeni, E.; Mazzetti, L.; Miotto, D.; Cascio, N. L.; Maestrelli, P.; Marian, E.; Querzoli, P.; Pedriali, M.; Murer, B. Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung Cancer 59:192-197; 2008.
10. Was, H.; Sokolowska, M.; Sierpniowska, A.; Dominik, P.; Skrzypek, K.; Lackowska, B.; Pratnicki, A.; Grochot-Przeczek, A.; Taha, H.; Kotlinowski, J. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic. Biol. Med. 51:1717-1726; 2011.
11. El Andaloussi, A.; Lesniak, M. S. CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J. Neurooncol. 83:145-152; 2007.
12. Nowis, D.; Legat, M.; Grzela, T.; Niderla, J.; Wilczek, E.; Wilczynski, G. M.; Głodkowska, E.; Mrówka, P.; Issat, T.; Dulak, J.; et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 25:3365-3374; 2006.
13. Kappas, A.; Drummond, G. S. Control of heme metabolism with synthetic metalloporphyrins. J. Clin. Invest. 77:335-339; 1986.
14. Hirai, K.; Sasahira, T.; Ohmori, H.; Fujii, K.; Kuniyasu, H. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int. J. Cancer 120:500-505; 2006.
15. Nowis, D.; Bugajski, M.; Winiarska, M.; Bil, J.; Szokalska, A.; Salwa, P.; Issat, T.; Was, H.; Jozkowicz, A.; Dulak, J.; et al. Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice. BMC Cancer 8:197; 2008.
16. Hill, M.; Pereira, V.; Chauveau, C.; Zagani, R.; Remy, S.; Tesson, L.; Mazal, D.; Ubillos, L.; Brion, R.; Ashgar, K. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: Mutual cross inhibition with indoleamine 2, 3-dioxygenase. FASEB J. 19:1957-1968; 2005.
17. Busserolles, J.; Megías, J.; Terencio, M. C.; Alcaraz, M. J. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int. Biochem. Cell Biol. 38:1510-1517; 2006.
18. Kuroda, H.; Takeno, M.; Murakami, S.; Miyazawa, N.; Kaneko, T.; Ishigatsubo, Y. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells. Lung Cancer 67:31-36; 2010.
19. Kweon, M. H.; Adhami, V. M.; Lee, J. S.; Mukhtar, H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem. 281:33761-33772; 2006.
20. Loboda, A.; Was, H.; Jozkowicz, A.; Dulak, J. Janus face of Nrf2-HO-1 axis in cancer-friend in chemoprevention, foe in anticancer therapy. Lung Cancer 60:1-3; 2008.
21. Rushworth, S. A.; Bowles, K. M.; Raninga, P.; MacEwan, D. J. NF-κB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction. Cancer Res. 70:2973-2983; 2010.
22. Lin, E.; Pollard, J. Role of infiltrated leucocytes in tumour growth and spread. Br. J. Cancer 90:2053-2058; 2004.
23. Mantovani, A.; Romero, P.; Palucka, A. K.; Marincola, F. M. Tumour immunity: Effector response to tumour and role of the microenvironment. Lancet 371:771-783; 2008.
24. Schmieder, A.; Michel, J.; Schönhaar, K.; Goerdt, S.; Schledzewski, K. Differentiation and gene expression profile of tumor-associated macrophages. Semin. Cancer Biol. 22:289-297; 2012.
25. Tsutsui, S.; Yasuda, K.; Suzuki, K.; Tahara, K.; Higashi, H.; Era, S. Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density. Oncol. Rep. 14:425-431; 2005.
26. Weis, N.; Weigert, A.; von Knethen, A.; Brüne, B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell 20:1280-1288; 2009.
27. Issat, T.; Nowis, D.; Legat, M.; Makowski, M.; Klejman, M. P.; Urbanski, J.; Skierski, J.; Koronkiewicz, M.; Stoklosa, T.; Brzezinska, A. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo. Int. J. Oncol. 30:1413-1426; 2007.
28. Li, G.; Tian, L.; Hou, J.; Ding, Z.; He, Q.; Feng, P.; Wen, Y.; Xiao, F.; Yao, B.; Zhang, R. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin. Cancer Res. 11:4217-4224; 2005.
29. Ben-Sasson, S. A.; Sherman, Y.; Gavrieli, Y. Identification of dying cells in situ staining. Methods Cell Biol. 46:29-39; 1995.
30. Jozkowicz, A.; Was, H.; Dulak, J. Heme oxygenase-1 in tumors: Is it a false friend? Antioxid. Redox Sign. 9:2099-2118; 2007.
31. Fang, J.; Sawa, T.; Akaike, T.; Akuta, T.; Sahoo, S. K.; Khaled, G.; Hamada, A.; Maeda, H. In vivo antitumor activity of pegylated zinc protoporphyrin targeted inhibition of heme oxygenase in solid tumor. Cancer Res. 63:3567-3574; 2003.
32. Long, J.; Manchandia, T.; Ban, K.; Gao, S.; Miller, C.; Chandra, J. Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1. Cancer Chemother. Pharm. 59:527-535; 2007.
33. Mayerhofer, M.; Florian, S.; Krauth, M. T.; Aichberger, K. J.; Bilban, M.; Marculescu, R.; Printz, D.; Fritsch, G.; Wagner, O.; Selzer, E. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res. 64:3148-3154; 2004.
34. Yoshida, C.; Yoshida, F.; Sears, D. E.; Hart, S. M.; Ikebe, D.; Muto, A.; Basu, S.; Igarashi, K.; Melo, J. V. Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood 109:1211-1219; 2007.
35. Kim, H. P.; Wang, X.; Nakao, A.; Kim, S. I.; Murase, N.; Choi, M. E.; Ryter, S. W.; Choi, A. M. K. Caveolin-1 expression by means of p38β mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc. Natl. Acad. Sci. USA 102:11319-11324; 2005.
36. Kim, H. P. Y. O.; Wang, X.; Galbiati, F.; Ryter, S. W.; Choi, A. M. K. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18:1080-1089; 2004.
37. Kim, D. S.; Chae, S. W.; Kim, H. R.; Chae, H. J. CO and bilirubin inhibit doxorubicin-induced cardiac cell death. Immunopharm. Immunother. 31:64-70; 2009.
38. Fang, J.; Sawa, T.; Akaike, T.; Greish, K.; Maeda, H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int. J. Cancer 109:1-8; 2003.
39. Yamashita, K.; Öllinger, R.; McDaid, J.; Sakahama, H.; Wang, H.; Tyagi, S.; Csizmadia, E.; Smith, N. R.; Soares, M. P.; Bach, F. H. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J. 20: 776-778; 2006.
40. McDaid, J.; Yamashita, K.; Chora, A.; Öllinger, R.; Strom, T. B.; Li, X. C.; Bach, F. H.; Soares, M. P. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T-cells. FASEB J. 19:458-460; 2005.
41. Walker, M. R.; Kasprowicz, D. J.; Gersuk, V. H.; Bènard, A.; Van Landeghen, M.; Buckner, J. H.; Ziegler, S. F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+ CD25 T-cells. J. Clin. Invest. 112:1437-1443; 2003.
42. Hayashi, S.; Takamiya, R.; Yamaguchi, T.; Matsumoto, K.; Tojo, S. J.; Tamatani, T.; Kitajima, M.; Makino, N.; Ishimura, Y.; Suematsu, M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress role of bilirubin generated by the enzyme. Circ. Res. 85:663-671; 1999.
43. Chauveau, C.; Rémy, S.; Royer, P. J.; Hill, M.; Tanguy-Royer, S.; Hubert, F. X.; Tesson, L.; Brion, R.; Beriou, G.; Gregoire, M. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106:1694-1702; 2005.
44. Fujiu, K.; Manabe, I.; Nagai, R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121:3425; 2011.
45. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35; 2003.
46. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555; 2002.
47. Sawle, P.; Foresti, R.; Mann, B. E.; Johnson, T. R.; Green, C. J.; Motterlini, R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264. 7 murine macrophages. Br. J. Pharmacol. 145:800-810; 2009.
48. Otterbein, L. E.; Bach, F. H.; Alam, J.; Soares, M.; Lu, H. T.; Wysk, M.; Davis, R. J.; Flavell, R. A.; Choi, A. M. K. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:422-428; 2000.
49. Morse, D.; Pischke, S. E.; Zhou, Z.; Davis, R. J.; Flavell, R. A.; Loop, T.; Otterbein, S. L.; Otterbein, L. E.; Choi, A. M. K. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. Sci. Signal. 278:36993; 2003.
50. Song, R.; Ning, W.; Liu, F.; Ameredes, B. T.; Calhoun, W. J.; Otterbein, L. E.; Choi, A. M. K. Regulation of IL-1βinduced GM-CSF production in human airway smooth muscle cells by carbon monoxide. Am. J. Physiol. Lung Cancer 284:L50-L56; 2003.